SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Blog
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
concurrent
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
2
1
feasibility, tolerability, and efficacy of the concurrent addition of erlotinib to thoracic radiotherapy in locally advanced unresectable non-small-cell lung cancer: a phase ii trial
2
a combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer
×
SciMatic on Your Phone
Track your articles, view certificates, and stay updated — anywhere, anytime.
Google Play